Breakthrough Genomics Unveils AI Tools and Largest Literature Database at ASHG 2025
Breakthrough Genomics showcased its largest interpreted literature database and unveiled new AI-driven capabilities at the American Society of Human Genetics (ASHG) 2025 Annual Meeting in Boston, announced in a press release.
The company highlighted updates to its Virtual Geneticist platform, which uses large language models to automate literature curation, ACMG classification, and clinical report generation. CEO Dr. Laura Li presented the system's ability to deliver up-to-date genetic evidence and reduce manual review time from hours to minutes while maintaining expert oversight.
Breakthrough Genomics also introduced Professor V, a chatbot designed for geneticists and researchers to explore biomedical literature and summarize evidence without hallucination. The company stated that its AI models enable higher-throughput rare disease diagnosis by improving variant prioritization and accelerating clinical reporting for whole exome and genome sequencing tests.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 22 Ping An Good Doctor Tests AI Medical Translation Service in Shenzhen Sep 22 Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board Sep 22 Amigo Rebrands as Concurrence Sep 22 CIPRA.ai and Murata Explore AI Wearables for Chronic Care Sep 22 CentralReach Releases ReportDraftAI for ABA ReportingLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Probably Genetic Gets Up to $10M ARPA-H Contract for Rare Disease AI
Google DeepMind Releases AlphaGenome Atlas With 9 Billion DNA Variant Predictions
Insilico Medicine Opens AI Longevity Research Toolkit
Ultima Genomics and NVIDIA Collaborate on Pangenome Sequencing Analysis
ADLM Calls for CLIA Rules to Cover AI in Laboratory Medicine
Daily AI Brief: the AI news that matters, in your inbox.